SOURCE: Global Developments, Inc.

November 21, 2006 14:32 ET

GLOBAL INVESTMENT UPDATE: Bio Life Remedies Announces Three New Products

VANCOUVER, BC--(Marketwire - November 21, 2006) - Global Developments, Inc. (PINKSHEETS: GBDP), a publicly traded venture capital company, is pleased to provide the following update with respect to Bio Life Remedies Inc., a manufacturer of health care products based on traditional Chinese medicine, in which Global holds an equity stake.

Bio Life Remedies Inc plans to produce an addition to its all natural Diabetes line of supplements. DIA FREE KIDS™ a supplement developed for the treatment of diabetes mellitus and its complications specifically formulated for children. It is pproduced from 100% organic natural flora and utilizes modern science and technology (flora broken cell wall technology) to help lower blood sugar levels in children. The Company plans to begin distributing this supplement on-line in North America by January 2007. For more information about diabetes mellitus and treatment with ZUTROL™ and BETATROL™ and DIA FREE KIDS™, please visit our website at www.blfrproducts.com.

Bio Life Remedies' has also developed 2 new herbal supplements derived from a Traditional Chinese Medicinal formula that has been used for centuries in China to treat Erectile Dysfunction. The first product, CHI - AGRA™, is developed to quickly and effectively treat ED. Formulated specifically for men with one easy dose of only 2 tablets 1 hour before sexual activity. The second product DI-AGRA™ was developed to treat symptoms of ED in men with Diabetes. The Company plans to launch both products in January 2007.

About Bio Life Remedies

BIO LIFE REMEDIES, INC. combines Traditional Chinese Medicine and Western academic research and development practices with the newest scientific technology to produce effective medical and health-care products to combat serious diseases. The Bio Life Group has developed 108 master medical formulas to treat various diseases including diabetes, prostateria, osteoporosis, cerebrovascular disease, cardiac vascular disease, hypertension, menopausal syndrome, and sexual disorders in men and women.

About Global Developments

Global Developments, Inc. is a publicly traded venture capital company. It was formed to create a unique investment vehicle representing a growing portfolio of innovative and emerging growth-oriented companies. Global acquires its portfolio companies either as wholly or partially owned subsidiaries, or as an investment where Global is the lead investor. As a result, Global maintains substantial management and operational control, thereby giving it the ability to provide significant oversight and guidance in building value and creating liquidity events for its shareholders. Global invests in companies with solid management, operational excellence, and the potential to grow substantial revenue streams. Please visit http://www.globaldevelopmentsinc.com for more information.

Forward-Looking Statements

You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as "will," "anticipates," "believes," "plans," "goal," "expects," "future," "intends," and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about Global Developments, Inc. please refer to its Web site at http://www.globaldevelopmentsinc.com.





Copyright © Hugin ASA 2006. All rights reserved.

Contact Information

  • Contact:

    Leighton Dean
    Shareholder Communications
    Tel:(604) 685-7552
    Toll Free: 1-866-907-GBDP(4237)
    Email Contact